The Prevalence of Rheumatoid Arthritis: A Systematic Review of Population-based Studies
- PMID: 33060323
- DOI: 10.3899/jrheum.200367
The Prevalence of Rheumatoid Arthritis: A Systematic Review of Population-based Studies
Abstract
Objective: To estimate the prevalence of rheumatoid arthritis (RA) from international population-based studies and investigate the influence of prevalence definition, data sources, classification criteria, and geographical area on RA prevalence.
Methods: A search of ProQuest, MEDLINE, Web of Science, and EMBASE was undertaken to identify population-based studies investigating RA prevalence between 1980 and 2019. Studies were reviewed using the Joanna Briggs Institute approach for the systematic review and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Results: Sixty studies met the inclusion criteria. There was a wide range of point prevalence reported (0.00-2.70%) with a mean of 0.56% (SD 0.51) between 1986 and 2014, and a mean period prevalence of 0.51% (SD 0.35) between 1955 and 2015. RA point and period prevalence was higher in urban settings (0.69% vs 0.48%) than in rural settings (0.54% vs 0.25%). An RA diagnosis validated by rheumatologists yielded the highest period prevalence of RA and was observed in linked databases (0.80%, SD 0.1).
Conclusion: The literature reports a wide range of point and period prevalence based on population and method of data collection, but average point and period prevalence of RA were 51 in 10,000 and 56 in 10,000, respectively. Higher urban vs rural prevalence may be biased due to poor case findings in areas with less healthcare or differences in risk environment. The population database studies were more consistent than sampling studies, and linked databases in different continents appeared to provide a consistent estimate of RA period prevalence, confirming the high value of rheumatologist diagnosis as classification criteria.
Keywords: database; epidemiology; prevalence; registries; rheumatoid arthritis.
Copyright © 2021 by the Journal of Rheumatology.
Similar articles
-
The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review.Rheumatol Int. 2021 May;41(5):863-877. doi: 10.1007/s00296-020-04731-0. Epub 2020 Nov 11. Rheumatol Int. 2021. PMID: 33175207
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.Vaccine. 2013 Dec 30;31 Suppl 10:K41-61. doi: 10.1016/j.vaccine.2013.03.075. Vaccine. 2013. PMID: 24331074 Review.
-
The validity of the claims-based definition of rheumatoid arthritis evaluated in 64 hospitals in Japan.BMC Musculoskelet Disord. 2021 Apr 22;22(1):373. doi: 10.1186/s12891-021-04259-9. BMC Musculoskelet Disord. 2021. PMID: 33888093 Free PMC article.
-
Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review.Semin Arthritis Rheum. 2006 Dec;36(3):182-8. doi: 10.1016/j.semarthrit.2006.08.006. Epub 2006 Oct 11. Semin Arthritis Rheum. 2006. PMID: 17045630 Review.
Cited by
-
Initial Treatment with Biological Therapy in Rheumatoid Arthritis.J Clin Med. 2023 Dec 21;13(1):48. doi: 10.3390/jcm13010048. J Clin Med. 2023. PMID: 38202055 Free PMC article. Review.
-
Safety and Effectiveness of Baricitinib in Chinese Patients with Moderate-to-Severe Rheumatoid Arthritis: 24-Week Results from a Post-Marketing Safety Study.Rheumatol Ther. 2023 Dec;10(6):1609-1622. doi: 10.1007/s40744-023-00596-4. Epub 2023 Sep 28. Rheumatol Ther. 2023. PMID: 37768505 Free PMC article.
-
An Atypical Presentation of Seronegative Rheumatoid Arthritis.Cureus. 2023 Mar 30;15(3):e36929. doi: 10.7759/cureus.36929. eCollection 2023 Mar. Cureus. 2023. PMID: 37131570 Free PMC article.
-
A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis.Br J Clin Pharmacol. 2023 Jan;89(1):61-79. doi: 10.1111/bcp.15579. Epub 2022 Nov 20. Br J Clin Pharmacol. 2023. PMID: 36326810 Free PMC article.
-
Predictive value of the TyG index and rheumatoid factor for cardiovascular disease risk in a rheumatoid arthritis population: data from a survey of 418 patients.Lipids Health Dis. 2022 Nov 17;21(1):122. doi: 10.1186/s12944-022-01735-6. Lipids Health Dis. 2022. PMID: 36397103 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous